Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:1834-1841
Published online before print March 12, 2009, doi: 10.1161/STROKEAHA.108.531269
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/5/1834    most recent
STROKEAHA.108.531269v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Desestret, V.
Right arrow Articles by Wiart, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Desestret, V.
Right arrow Articles by Wiart, M.
Related Collections
Right arrow Animal models of human disease
Right arrow Computerized tomography and Magnetic Resonance Imaging

(Stroke. 2009;40:1834.)
© 2009 American Heart Association, Inc.


Original Contributions

Early-Stage Investigations of Ultrasmall Superparamagnetic Iron Oxide-Induced Signal Change After Permanent Middle Cerebral Artery Occlusion in Mice

Virginie Desestret, MD; Jean-Christophe Brisset, MSc; Samir Moucharrafie, MD; Emilie Devillard, BSc; Serge Nataf, MD, PhD; Jérôme Honnorat, MD, PhD; Norbert Nighoghossian, MD, PhD; Yves Berthezène, MD, PhD Marlène Wiart, PhD

From the Université Lyon 1, F-69622 (V.D., J.-C.B., S.M., S.N., J.H., N.N., Y.B., M.W.), Lyon, France; INSA de Lyon, F-69621 (V.D., J.-C.B., E.D., N.N., Y.B., M.W.), Villeurbanne, France; CNRS, UMR5220 (V.D., J.-C.B., E.D., N.N., Y.B., M.W.), Creatis, France; Inserm, U630, (V.D., J.-C.B., E.D., N.N., Y.B., M.W.), Creatis, France; and Inserm, U842 (E.D., S.N., J.H.), Lyon, France.

Correspondence to Marlène Wiart, PhD, Creatis-LRMN, CNRS 5220, U630 Inserm, Hôpital Neuro-Cardiologique, 28 avenue de Doyen Lepine, 69677 Bron Cedex, France. E-mail marlene.wiart{at}creatis.univ-lyon1.fr

Background and Purpose— MR signal changes after intravenous ultrasmall superparamagnetic iron oxide (USPIO) injection are related to inflammatory cells at the subacute stages after focal cerebral injury. However, at the early stages, the interpretation of USPIO-related MR signal alterations remains controversial. Here, we compared MR signal changes after intravenous USPIO injection with the histological iron and macrophage distribution during the first 24 hours in a rodent model of acute stroke.

Methods— Multiparametric MRI at 7T and histological USPIO distribution were confronted from 6 to 24 hours after permanent middle cerebral artery occlusion in mice. Blood–brain barrier disruption was assessed using gadolinium MRI and immunoglobulin staining. Prussian blue staining was performed to depict the USPIO brain distribution. USPIO uptake by phagocytes was assessed by immunochemistry on brain tissue, peripheral blood cells, and monocyte cells derived from bone marrow culture.

Results— After USPIO injection, 4 areas of early signal change were observed on every MRI. In all these areas, iron particles were mostly free whether detected in the vascular and cerebrospinal fluid compartments or in the interstitium. Within the first 24 hours, USPIO-loaded cells were not detected in the blood of injured mice or in cultured monocytic cells incubated with USPIO at plasmatic concentration.

Conclusions— These results suggest that, in this model, early reproducible USPIO-related MR signal changes are mainly caused by passive diffusion of free USPIO after blood–brain barrier leakage and by intravascular trapping rather than by peripheral phagocyte infiltration.


Key Words: brain ischemia • inflammation • magnetic resonance imaging • ultrasmall superparamagnetic particles of iron oxide